Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canter, R. J.
Right arrow Articles by Fraker, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canter, R. J.
Right arrow Articles by Fraker, D. L.
Annals of Surgical Oncology 10:514-524 (2003)
© 2003 Society of Surgical Oncology


NEW APPROACHES TO THE TREATMENT OF HEPATIC MALIGNANCIES

Intraperitoneal Photodynamic Therapy Causes a Capillary-Leak Syndrome

Robert J. Canter, MD, Rosemarie Mick, MS, Susan B. Kesmodel, MD, Dan J. Raz, MD, Francis R. Spitz, MD, James M. Metz, MD, Eli J. Glatstein, MD, Stephen M. Hahn, MD and Douglas L. Fraker, MD

From the Departments of Surgery (RJC, SBK, DJR, FRS, DLF), Biostatistics and Epidemiology (RM), and Radiation Oncology (JMM, EJG, SMH), University of Pennsylvania, Philadelphia, Pennsylvania.

Correspondence: Address correspondence and reprint requests to: Douglas L. Fraker, MD, Division of Surgical Oncology, Department of Surgery, University of Pennsylvania Medical Center, 3400 Spruce Street, 4 Silverstein, Philadelphia, PA 19104; Fax: 215-662-3629; E-mail: frakerd{at}uphs.upenn.edu

ABSTRACT

Background: In patients undergoing intraperitoneal (IP) photodynamic therapy (PDT), the combination of aggressive surgical debulking and light therapy causes an apparent systemic capillary-leak syndrome that necessitates significant intensive care unit (ICU) management after surgery.

Methods: From May 1997 to May 2001, 65 patients underwent surgical debulking and PDT as part of an ongoing phase II trial for disseminated IP cancer. Perioperative data were reviewed retrospectively, and statistical analyses were performed to determine whether any identifiable factors were associated with the need for mechanical ventilation for longer than 1 day and with the occurrence of postoperative complications.

Results: Forty-three women and 22 men (mean age, 49 years) were treated. Operative time averaged 9.8 hours, and mean estimated blood loss was 1450 mL. The mean crystalloid requirement for the first 48 hours after surgery was 29.3 L, and 49 patients required blood products. Twenty-four patients were intubated for longer than 24 hours, with a mean of 8.3 days for those intubated longer than 1 day. The median ICU stay was 4 days. Overall, 110 complications developed in 45 (69%) of the 65 patients. Significant complications included 6 patients with acute respiratory distress syndrome, 28 patients with infectious complications, and 4 patients with anastomotic complications. Statistical analyses revealed that surgery-related factors were significantly associated with these complication outcomes.

Conclusions: Patients who undergo surgical debulking and IP PDT develop a significant capillary-leak syndrome after surgery that necessitates massive volume resuscitation, careful ICU monitoring, and, frequently, prolonged ventilatory support.

Key Words: Photodynamic therapy • Carcinomatosis • Sarcomatosis • Capillary-leak syndrome




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. M. Hahn, D. L. Fraker, R. Mick, J. Metz, T. M. Busch, D. Smith, T. Zhu, C. Rodriguez, A. Dimofte, F. Spitz, et al.
A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis
Clin. Cancer Res., April 15, 2006; 12(8): 2517 - 2525.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. G. del Carmen, I. Rizvi, Y. Chang, A. C. E. Moor, E. Oliva, M. Sherwood, B. Pogue, and T. Hasan
Synergism of Epidermal Growth Factor Receptor-Targeted Immunotherapy With Photodynamic Treatment of Ovarian Cancer In Vivo
J Natl Cancer Inst, October 19, 2005; 97(20): 1516 - 1524.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society of Surgical Oncology.